Home
About
Overview
Sharing Data
ORCID
Help
History (118)
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism.
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Oral 5-FU alternatives for the treatment of head and neck cancer.
See All 118 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral 5-FU alternatives for the treatment of head and neck cancer.
Oral 5-FU alternatives for the treatment of head and neck cancer. Oncology (Williston Park). 1998 Oct; 12(10 Suppl 7):35-8.
View in:
PubMed
subject areas
Administration, Oral
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Etoposide
Fluorouracil
Head and Neck Neoplasms
Humans
Hydroxyurea
Neoplasm Recurrence, Local
Tegafur
Uracil
authors with profiles
Daniel Haraf
Bruce E. Brockstein